-Search- Users Labs Protocols News Archive Blog Archive Forum

Search



Firefox

Internet Explorer 7

Safari (Mac and PC) You are not using a standards compliant browser. Because of this you may notice minor glitches in the rendering of this page. Please upgrade to a compliant browser for optimal viewing:

Press Release

Molecular master switch for pancreatic cancer identified, potential predictor of treatment outcome

Thanks to University of Pennsylvania School of Medicine for this article.

This press release was posted to serve as a topic for discussion. Please comment below. We try our best to only post press releases that are associated with peer reviewed scientific literature. Critical discussions of the research are appreciated. If you need help finding a link to the original article, please contact us on twitter or via e-mail.

Comments Page: 1 Rick Kern



Guest Comment Thu, Feb 14, 2013, 2:47 am CST I read about a researcher in China named Rongxiang Xu who's working on stem cell treatments that can be administered so stem cell cultivation could be handled entirely in situ. It sounds like these could be complementary technologies. Has Labspaces covered Xu before? Page: 1 Add Comment? Comments are closed 2 weeks after initial post.

This press release has been viewed 8244 time(s).